EASL 2026 Interview: Ana Lleo
Hepatologist Ana Lleo discusses her career path and the evolution of liver disease research, highlighting the shift from viral hepatitis to metabolic dysfunction-associated steatotic liver disease (MASLD). She emphasizes the critical role of international collaboration in addressing rare liver conditions.
Ana Lleo | P rofessor of Internal Medicine , Humanitas University ; Consultant Hepatologist and H ead of the Center for Autoimmune Liver Diseases , Division of Internal Medicine and Hepatology, IRCCS Humanitas Research Hospital; Head of the Hepatobiliary Immunopathology Laboratory, Humanitas Research Hospital, Milan, Italy
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in